Skip to main content

Day: March 11, 2021

USA Rare Earth Participates in Search Minerals Private Placement With Strategic Investment of $630,000 (CDN)

VANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY) (“Search” or the “Company”) and USA Rare Earth, LLC (“USA Rare Earth”) are pleased to announce that USA Rare Earth, LLC purchased 9,000,000 units at $0.07 per unit for proceeds of $630,000 CDN in the Company’s most recent financing that closed on March 11, 2021.On November 10, 2020, Search and USA Rare Earth jointly announced a Technical Collaboration Framework Agreement whereby the two companies would work on several initiatives.  USA Rare Earth is the funding and development partner of the Round Top Heavy Rare Earth, Lithium and Critical Minerals Project in Hudspeth County, West Texas, together with Texas Mineral Resources Corp. (OTCQB: TMRC). As part of Search’s and USA Rare Earth’s development plans, the companies intend to expand...

Continue reading

C4 Therapeutics Reports Recent Business Highlights and Full Year 2020 Financial Results

– Phase 1/2 Trial for Lead Candidate CFT7455, a MonoDAC™ Degrader Targeting IKZF1/3 for the Treatment of Hematologic Malignancies, On Track for 1H 2021 Initiation Following FDA Clearance of Investigational New Drug (IND) –                  – Abstract Highlighting the Discovery and Preclinical Development of CFT7455 Accepted for Presentation in the Late Breaking Mini-Symposium at AACR in April –– IND Application Submission for CFT8634, a BiDAC™ Degrader targeting BRD9 for Synovial Sarcoma and SMARCB1-deleted Tumors, Planned for 2H 2021 –– Year-End 2020 Cash, Cash Equivalents and Marketable Securities of $372M Expected to Provide Runway to End of 2023 –WATERTOWN, Mass., March 11, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule medicines that selectively...

Continue reading

Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update

Strengthened Balance Sheet with $25.3 Million of Gross Proceeds from Financings and Warrant ExercisesInitiation of Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients Anticipated in the First Quarter of 2021HST 003 Trial Initiation for Cartilage Regeneration in the Knee Anticipated in the Second Quarter of 2021Appointment of Industry Leader Dr. Susan Windham-Bannister to Board of DirectorsSAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today reported financial results for the fourth quarter and year ended December 31, 2020 and provided an update on its clinical pipeline and other corporate developments.“Throughout...

Continue reading

Quest Resource Holding Corporation Reports 2020 Financial Results

THE COLONY, Texas, March 11, 2021 (GLOBE NEWSWIRE) — Quest Resource Holding Corporation (NASDAQ: QRHC) (“Quest”), a national leader in environmental waste and recycling services, today announced financial results for the fourth quarter and year ended December 31, 2020.Fourth Quarter 2020 HighlightsRevenue was $27.7 million, a 20.5% increase compared with the fourth quarter of 2019.Gross profit was $5.6 million, a 19.7% increase compared with the fourth quarter of 2019.Gross margin was 20.2% of revenue compared with 20.3% for the fourth quarter of 2019.Net income per share attributable to common stockholders was $0.01, compared with $0.00 per share during the fourth quarter of 2019.Adjusted EBITDA was $1.8 million, a 110.3% increase compared with the fourth quarter of 2019.Year ended December 31, 2020 HighlightsRevenue...

Continue reading

COMPAGNIE LEBON : Capital et droits de vote février 2021

 Middle Office EmetteurTél. : 01 53 48 80 10 – Fax : 01 49 74 32 77 – 34318@cic.frCOMPAGNIE LEBONDate d’arrêté:28/02/2021ARTICLE 223-16 du règlement général de l’AMFActions du capital1 173 000Droits de vote théoriques (1)2 157 763Actions privées de droits de voteAutodétention au nominatif (2)31 218Autodétention au porteur * (3)0Autres * (4)0* à compléter par la sociétéDroits de vote exerçables*2 126 545*= (1) – [(2) + (3) + (4)]Pour information :Nombre de Comptes Courants Nominatifs2 266Pièce jointeDDV Compagnie Lebon 28 02 2021

Continue reading

First Patients Enrolled in the Merit WRAPSODY AV Access Efficacy Pivotal Study

SOUTH JORDAN, Utah, March 11, 2021 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today the enrollment of the first patients in its Wrapsody ArterioVenous (AV) Access Efficacy Pivotal Study (the “WAVE Study”) of the WRAPSODY™ Endovascular Stent Graft, an investigational device being studied for the treatment of stenosis or occlusion within dialysis outflow circuits. Jeffrey Hoggard, MD at RAC Surgery Center LLC, Raleigh, NC successfully enrolled the first two subjects with venous outflow peripheral lesions.“We are pleased to announce the first subjects enrolled into the Merit Medical WAVE...

Continue reading

Mullen Technologies Announces Purchase of Advanced Engineering and Manufacturing Center in Tunica, MS

BREA, Calif., March 11, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Technologies Inc. (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, which previously announced a definitive agreement to merge with Net Element, Inc. (NASDAQ: NETE) in a stock-for-stock reverse merger in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company, has executed a purchase and sales agreement (PSA) and opened escrow to purchase a EV manufacturing facility in Tunica, Mississippi. This five-year-old, turn-key facility affords Mullen the opportunity to innovate its manufacturing processes, while having the availability to assemble vehicles now and optimize product design with simultaneous engineering efforts. Under Mullen ownership, the facility will be known as Mullen’s...

Continue reading

GAUMONT : Résultats annuels consolidés au 31 décembre 2020

Communiqué de presseNeuilly-sur-Seine, le 11 mars 2021Le Conseil d’administration de Gaumont, réuni le 11 mars 2021 sous la présidence de Nicolas Seydoux, a arrêté les comptes au 31 décembre 2020.RESULTATS ANNUELS CONSOLIDES au 31 décembre 2020L’année 2020 a été marquée par la crise sanitaire liée au Covid-19 en France et dans l’ensemble des pays où intervient le groupe. Ses principaux effets sur l’exploitation ont été la fermeture au public des salles de cinéma pour une durée variable d’un pays à l’autre d’une part, et d’autre part, la suspension des tournages au premier semestre avant leur reprise avec des normes sanitaires renforcées.n CHIFFRE D’AFFAIRES 2020Le chiffre d’affaires consolidé de l’année 2020 s’élève à M€ 154,0 contre M€ 212,1 l’année précédente.      o  Production cinématographiqueLe chiffre d’affaires de l’activité de...

Continue reading

Victory Square Technologies Inc. Announces Closing of GameOn’s Oversubscribed Financing for Gross Proceeds of $5.8 Million

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICESVANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (CSE: VST, OTC: VSQTF, FWB: 6F6) (the “Company” or “VST“) is pleased to announce that its portfolio company GameOn Entertainment Technologies Inc. (“GameOn“) has closed its previously announced and oversubscribed non-brokered private placement financing (the “Financing“) of 16,505,536 subscription receipts (the “Subscription Receipts“) at a price of $0.35 per Subscription Receipt, for gross proceeds of approximately $5.8 million.The proceeds of the Financing (the “Escrowed Funds“) have been deposited in escrow pursuant to the terms of a subscription receipt agreement (the “Subscription...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.